DOROTHY ADAIR: Open Payments
NPI 1639392699 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,757 in 58 payments from 19 companies in 2025. Trend: 2023 $281 · 2024 $383 · 2025 $2,757
Food & beverage: $1,916Travel & lodging: $840
| Company | Payments | Amount |
|---|---|---|
| Microtransponder, Inc. | 3 | $1,249 |
| UCB, Inc. | 7 | $295 |
| ARGENX US, INC. | 6 | $181 |
| Teva Pharmaceuticals USA, Inc. | 9 | $173 |
| Novartis Pharmaceuticals Corporation | 6 | $159 |
| Janssen Biotech, Inc. | 3 | $96 |
| Lundbeck LLC | 4 | $89 |
| Eisai Inc. | 3 | $88 |
| Alexion Pharmaceuticals, Inc. | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
Products named: VYVGART HYTRULO, AUSTEDO XR, KESIMPTA, Fintepla, VYEPTI, Leqembi, ULTOMIRIS, Nayzilam.
Industry payments across FL — which companies pay providers there.
